Allergan and Paratek nail pivotal acne trial, while Foamix makes a late-stage stumble
It's good news and bad news on the acne front, based on two Phase 3 readouts delivered Monday.
It's good news and bad news on the acne front, based on two Phase 3 readouts delivered Monday.